[EN] INHIBITORS OF PROTEASE-ACTIVATED RECEPTOR-2<br/>[FR] INHIBITEURS DU RÉCEPTEUR-2 ACTIVÉ PAR UNE PROTÉASE
申请人:ASTRAZENECA AB
公开号:WO2017194716A1
公开(公告)日:2017-11-16
The present application relates to certain substituted imidazole and triazole compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating pain, musculoskeletal inflammation, neuroinflammatory disorders, airway inflammation, itch, dermatitis, colitis and related conditions. The compounds are of Formula (I) where X is N or CH, Z and Y are N or C (but both not N) and R1-R3 are as defined herein.
ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE
申请人:Samsung Electronics Co., Ltd.
公开号:US20210253618A1
公开(公告)日:2021-08-19
An organometallic compound represented by Formula 1:
M(L
1
)
n1
(L
2
)
n2
Formula 1
In Formula 1, M is a transition metal; L
1
is a ligand represented by Formula 2 as disclosed herein; L
2
is a monodentate ligand, a bidentate ligand, a tridentate ligand, or a tetradentate ligand; n1 is 1, 2, or 3, wherein, when n1 is 2 or greater, two or more ligands L
1
are identical to or different from each other; n2 is 0, 1, 2, 3, or 4, wherein, when n2 is 2 or greater, two or more ligands L
2
are identical to or different from each other; and L
1
and L
2
are different from each other.